Profile
Morgan Sheng is a Professor at the Massachusetts Institute of Technology.
He was previously an Independent Director at Prevail Therapeutics, Inc. from 2019 to 2021 and a Vice President-Neuroscience at Genentech, Inc. He holds a doctorate degree from Harvard University and the University of London, and an undergraduate degree from the University of Oxford.
Morgan Sheng active positions
| Companies | Position | Start |
|---|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Morgan Sheng
| Companies | Position | End |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Director/Board Member | 21/01/2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Training of Morgan Sheng
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prevail Therapeutics, Inc.
Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Morgan Sheng
















